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The present study explains the neuroprotective ability of bioactive fractions of Annona
reticulata bark (ARB) and Ziziphus jujuba root bark (ZJ) along with insulin against diabetic
neuropathy. By using different solvents of increasing polarity ARB and ZJ were undergone
for bioactive guided fractionation. The neuroprotective ability of the all the plant fractions
were tested against H2O2 induced toxicity in SHSY5Y neuroblastoma cell lines and
DRG neuronal cells. Among all the fractions tested, the methanol extract of ARB and
ZJ (ARBME and ZJME) and its water fractions (ARBWF and ZJWF) exhibited significant
neuroprotection against H2O2 induced toxicity in SHSY5Y cells and DRG neuronal cells.
Further both the active fractions were tested against streptozotocin (55 mg/kg i.p.)
induced diabetic neuropathy in male Wistar rats. Body weight changes, blood glucose
levels and pain threshold through hot plate, tail immersion, cold plate and Randall-Sillitto
methods were measured throughout the study at weekly interval. After completion of the
drug treatment period, all the animals were sacrificed to measure the sciatic nerve lipid
peroxidation, antioxidative enzyme levels (SOD, catalase, and GSH) and cytokine levels
(IL-1β, IL-6, IL-10, TNF-α, iNOS, and NFκB) through ELISA and western blotting analysis.
Results of this study explain that ARBME, ZJME, ARBWF, and ZJWF along with insulin
potentially attenuate the thermal, mechanical hyperalgesia and cold allodynia in diabetic
neuropathic rats, where insulin treatment alone failed to diminish the same. Reduction
of sciatic nerve oxidative stress, NF-κB and iNOS mediated inflammatory cascade and
normalization of abnormal cytokine release confirms the possible mechanism of action.
The present study confirms the neuroprotective ability of ARB and ZJ against painful
diabetic neuropathy through inhibiting oxidative stress and NF-κB inflammatory cascade.
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INTRODUCTION
According to the World Health Organization (WHO) report
by 2014, 422 million world populations are suffering from
diabetes, which gives the status of an epidemic around the globe.
Prolonged or untreated diabetic patients suffer from a chronic
condition called neuropathy which diminishes the quality life
of wellbeing. Around 20–24% of diabetic patients suffer from
diabetic neuropathy (DN). Pain is the main symptom of DN,
which is characterized by thermal, mechanical hyperalgesia
and cold allodynia. The mechanism behind precipitation of
diabetic neuropathic pain (DNP) is still unclear (Dyck et al.,
2000; Kaeidi et al., 2011; Kandhare et al., 2012). Hyperglycemia
and its associated metabolic disarrangements are the primary
cause of deterioration of neurons and DNP. The experimental
and clinical evidences concluded that long term hyperglycemic
condition mediated cellular dysfunctions plays a pivotal role
in nerve injury through oxidative stress, cytokine release
and neuro-inflammation. Increased blood glucose level also
causes the activation of polyol pathway and advanced glycation
end products (AGEs) which in turn stimulates the NF-κB
inflammatory cascade and releases the oxidants (Yagihashi et al.,
2011; Babizhayev et al., 2015).
Reports suggested that treatment with anti-oxidant molecules
along with strict hyperglycemic control attenuates the DNP
(Yagihashi et al., 2011). Where, strict glycemic control alone
through insulin therapy can not diminish the risk (Tiwari
et al., 2011). Current drug treatment regimen is incapable to
completely relief the DNP, which includes anti-hyperglycemics,
sodium and calcium channel blockers, opioids, anti-depressants,
anticonvulsants, etc. This complex medication can leads to
serious side effects that diminish the quality of life and increases
the financial burden on patients. Despite having a large number
of drugs in the market still, the management of diabetic
complications is a substantial challenge (Honore et al., 2011;
Peng et al., 2015). Various reports from preclinical data suggested
that herbal extracts from Curcuma longa, Tribulus terrestris,
Emblica officinalis (Ranjithkumar et al., 2013) have beneficial
effects in the management of DNP. In this study, we evaluated
the neuroprotective ability of two medicinal plants Ziziphus
jujuba and Annona reticulata against painful DNP. These two
plants have been using for curing different diseases like diabetes,
inflammation and liver ailments by various tribal communities
of northeast India but there is no scientific validation for the
same. Bioactive fractions of these two plants (A. reticulata and
Z. jujuba) have the ability to protect the hepatocytes and reduce
the inflammation (Kandimalla et al., 2016a,e).
Ziziphus jujuba Mill. (Rhamnaceae) commonly known as
Indian date or red date, a spiny shrub to small tree widely
available in tropical and warm subtropical regions around the
world. This plant is widely used in traditional system of medicine
for different ailments like diabetes, inflammation, infections,
liver diseases, and throat problems by local tribal peoples in
India (Naik et al., 2013). Z. jujuba contains phenolic and
flavonoid compounds (San and Yildirim, 2010; Wang et al.,
2016), polysaccharides (Yue et al., 2014), triterpenoid acids
(Guo et al., 2009), alkaloids and glycoside compounds (Meng
et al., 2013). Different plant parts of Z. jujuba were reported
to have antioxidant (Sun et al., 2011), anti-inflammatory (Yu
et al., 2012), hepatoprotective, anti-tumor (Hoshyar et al., 2015)
and induction of erythropoietin expression (Lam et al., 2016)
activities.
Annona reticulata L. (AR) is a small tree belongs to the
family Annonaceae which is widely available in tropical regions
of the world, especially in India, China, America, and West
Indies (Rahman et al., 2011). Various reports suggests that AR
traditionally used as antiparasitic, antidiarrhoeic, antidysenteric
and insecticide (Wele et al., 2008). Different parts of the plant
were reported to have anticancer, analgesic, anti-inflammatory,
antiulcer, antioxidant, hepatoprotective, and wound healing
properties (Jamkhande and Wattamwar, 2015; Kandimalla et al.,
2016a). The plant has been reported for different phytochemicals
like cycloreticulins A and B, cyclooctapeptides (Wele et al., 2008),
acetogenins (Chang et al., 1998), cycloreticulin C, glabrin A,
cyclopeptides (Wele et al., 2009).
To treat the DNP condition, single therapeutic agent is not
sufficient as the drug has to act on the hyperglycemia, oxidative
stress and nerve inflammation simultaneously (Sandireddy et al.,
2014). Plants are the source for a vast number of bioactive
phytoconstituents which have the potential to treat the disease
and related complications together. The present study was aimed
to investigate the ability of bioactive guided fractions of Z. jujuba
root bark andA. reticulata bark along with insulin against painful
diabetic neuropathy. To achieve the goal initially we evaluated
the neuroprotective ability of all the plant extract and fractions
against SHSY5Y cell line and isolated Dorsal Root Ganglion
(DRG) neurons. Further, the active fractions from the in vitro
study were screened against STZ induced DNP in rats. Findings
of the study will give insight regarding successful translation of
multicomponent therapeutic strategy for the treatment of DNP.
MATERIALS AND METHODS
Chemicals
3-(4,5-dimethyl thiazol-2-yl)-5-diphe- nyl tetrazolium bromide
(MTT), trypan blue and trypsin were obtained from Sigma-
Aldrich Co, St Louis, USA. Cell culture media and fetal bovine
serum (FBS) were procured from Invitrogen, Life technologies,
USA. TNF-α, IL-1β, IL-6, and IL-10 ELISA kits were obtained
from RandD systems. Antibodies and nitrocellulose membrane
were purchased from Cell Signaling, USA. Superoxide dismutase
(SOD) and catalase (CAT) assay kits were procured from
Cayman, USA. Biochemical kits were purchased from Accurex
Biomedical Pvt. Ltd, Mumbai. Insulin was procured fromAbbott,
India LTD. All the other chemicals used in this study were of
analytical grade and obtained from Sigma-Aldrich Co, St Louis,
USA and Merck, Germany.
Plant Collection, Identification, Extraction,
and Bioactive Guided Fractionation of
Plant Materials
The detailed description for the plant collection, identification,
extraction and bioactive guided fractionation of both the plantsZ.
jujuba root bark and A. reticulata was previously reported from
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our research group (Kandimalla et al., 2016a,e). Figure 1 depicts
the schematic representation of the bioactive guided fraction.
Evaluation of the Effect of Plant Fractions
on H2O2 Intoxicated SHSY5Y Cell lines and
DRG neurons
Cell Lines and Maintenance
The SHSY5Y neuroblastoma cell line was procured from
National Center for Cell sciences (NCCS), Pune, Maharashtra,
India. The cells were maintained in culture flasks containing
DMEM media supplemented with FBS and antibiotic solution
(Sigma-Aldrich, USA) in a humidified 5% CO2 incubator at
37◦C. Every 2 days the culture medium was replaced with new
medium.
For isolation of DRG neuron cells, male wistar rats (2 months
old) were anesthetized using ketamine and xylazine cocktail (80
and 10 mg/kg) and the neurons were carefully collected from
peripheral nerve roots. The neurons were incubated in DMEM
supplemented with 1% streptomycin- penicillin (Sigma-Aldrich,
USA). Further connective tissues were removed and ganglia were
treated with collagenase-IV (0.28 ml in DMEM), and trypsin
(25,000 units/ml in DMEM) for 45 min and incubated at 37◦C in
CO2 incubator. The resulting cell suspension was filtered through
74 µm filter and centrifuged at 1,500 g and further proceed for
culturing (Naziroglu et al., 2013; De Luca et al., 2015).
Neuroprotective Ability of Z. jujuba and
A. reticulata Fractions
By using the cell viability (MTT) assay the neuroprotective ability
of A. reticulata methanol extract and its fractions (ARBME,
ARBHF, ARBCF, ARBEAF, ARBWF, and ARBMR) and Z. jujuba
FIGURE 1 | Schematic representation of bioactive guided fractionation
of A. reticulata bark and Z. jujuba root bark. ARBME, A. reticulata bark
methanol extract; ARBHF, A. reticulata bark hexane fraction; ARBCF,
A. reticulata bark chloroform fraction; ARBEAF, A. reticulata bark ethyl acetate
fraction; ARBWF, A. reticulata bark water fraction; ARBMR, A. reticulata bark
methanol residue; ZJME, Z. jujuba root bark methanol extract; ZJHF, Z. jujuba
root bark hexane fraction; ZJCF, Z. jujuba root bark chloroform fraction; ZJEAF,
Z. jujuba root bark ethyl acetate fraction; ZJWF, Z. jujuba root bark water
fraction; ZJMR, Z. jujuba root bark methanol residue.
methanol extract and its fractions (ZJME, ZJHF, ZJCF, ZJEAF,
ZJWF, and ZJMR) were determined. Briefly, SHSY5Y cells
(1× 104 cells/well) were seeded into 96 well plates and incubated
overnight in a CO2 incubator at 37
◦C. The next day morning
culture media from the plate was replaced with fresh media. Cells
were pretreated with plant fractions at different concentrations
(0, 0.5, 5, and 50 µg/ml) and incubated for 12 h before the
cells were exposed to 100 µM H2O2 for next 12 h. After 24
h of the total incubation period, cell viability was evaluated by
MTT assay (Kalita et al., 2015; Kalita S. et al., 2016; Kandimalla
et al., 2016b). To each well 10 µl of 4 mg/ml MTT solution was
added and incubated at 37◦C for 2 h. After the incubation period,
the MTT solution was removed from the wells and 100 µl of
DMSO solution was added to dissolve the formazan crystals. The
color intensity was measured at 560 nm using ELISA microplate
reader (Thermo Scientific, USA). Cells were exposed to different
treatment groups as given below:
Group-I (control):
Normal control: Cells treated with 100µl of serum free culture
medium for 24 h.
DMSO control: Cells treated with 100 µl of serum free culture
medium containing DMSO (0.25% v/v) for 24 h.
A. reticulata fractions Control: Cells treated with 100 µl
of serum free culture medium containing ARBME, ARBHF,
ARBCF, ARBEAF, ARBWF, and ARBMR (200 µg/ml) separately
for 24 h.
Z. jujuba fractions control: Cells treated with 100 µl of serum
free culture medium containing ZJME, ZJHF, ZJCF, ZJEAF,
ZJWF, and ZJMR (200 µg/ml) separately for 24 h.
Group-II (H2O2 treatment): Cells treated with 100 µl of
serum free culture medium containing 100 µMH2O2 for 12 h.
Group-III (A. reticulata Fractions Treatment): Cells treated
with 100 µl of serum free culture medium containing ARBME,
ARBHF, ARBCF, ARBEAF, ARBWF, and ARBMR (at 50, 100, and
200 µg/ml) separately for 12 h+ 100 µMH2O2 for next 12 h.
Group-IV (Z. jujuba fractions treatment): Cells treated with
100 µl of serum free culture medium containing ZJME, ZJHF,
ZJCF, ZJEAF, ZJWF, and ZJMR (at 50, 100, and 200 µg/ml)
separately for 12 h+ 100 µMH2O2 for next 12 h.
Measurement of Lactate Dehydrogenase
(LDH) Levels and Lipid Peroxidation
Culture media from the all the treatment groups were collected
after the drug treatment period to measure the LDH levels.
Briefly, the culture media was centrifuged at 2,000 rpm for 15
min, and the supernatant was collected tomeasure the LDH levels
using Ecoline diagnostic kit as per the instructions provided
by the manufacturer. Each sample was performed in triplicate
and, the results were expressed in U/L. Cells from the wells
were scrapped and transferred to RIPA lysis buffer. The protein
concentration was determined by Lowrymethod and TBARS was
estimated by following Ohkawa et al. (1979).
Neuroprotective Ability of Active Plant
Fractions against DRG Cells
DRG cells were cultured in a poly-D-lysine pre coated 96 well
plate at 2× 104 cells/well and treatments were given as following:
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Normal control: DRG cells treated with 100 µl of serum free
culture medium for 24 h.
DMSO control: DRG cells treated with 100 µl of serum free
culture medium containing DMSO (0.1% v/v) for 24 h.
A. reticulata fractions Control: DRG cells treated with 100 µl
of serum free culture medium containing ARBME and ARBWF
(200 µg/ml) separately for 24 h.
Z. jujuba fractions control: DRG cells treated with 100 µl of
serum free culture medium containing ZJME and ZJWF (200
µg/ml) separately for 24 h.
Group-II (H2O2 treatment): DRG cells treated with 100 µl
of serum free culture medium containing 100 µMH2O2 for 12 h.
Group-III (A. reticulata fractions treatment): DRG cells
treated with 100 µl of serum free culture medium containing
ARBME and ARBWF (at 50, 100, and 200 µg/ml) separately for
12 h+ 100 µMH2O2 for next 12 h.
Group-IV (Z. jujuba fractions treatment):DRG cells treated
with 100 µl of serum free culture medium containing ZJME and
ZJWF (at 50, 100, and 200 µg/ml) separately for 12 h + 100 µM
H2O2 for next 12 h.
After 24 h of incubation MTT assay was performed to
determine the percentage cell viability.
Acute Toxicity Studies
OECD (Organization for Economic Co-operation and
Development) guidelines to test chemicals were followed to
perform the acute oral toxicity studies. Swiss albino mice
of either sex (n = 5) were selected randomly for this study.
Mice were fasted overnight with free access to water before
administration of test drugs. A single dose of ARBME, ARBWF,
ZJME, and ZJWF at 2,000 mg/kg and same dose along with 5
IU/kg of insulin was administered separately to three animals
each. Animals kept under observation for 14 days and the
dose was considered as toxic if mortality observed in 2 out of
3 animals. The experiment was repeated to confirm the toxic
dose if mortality observed in 1 out of 3 animals. The study was
continued with small doses (300, 50, and 5 mg/kg body weight)
on finding the dose as toxic again (Choudhury et al., 2016).
Animals and Induction of Diabetes
Adult male Wistar rats weighing 200–220 gm were used to
conduct the in vivo experiments. Animals were housed four per
cage and maintained at 24◦C ± 1◦C, with a relative humidity
of 45–55% and 12:12 h dark/light cycle and had free access to
standard pellet diet (Provimi Animal Nutrition Pvt. Ltd., India)
and water throughout the experimental period. All experiments
were carried out between 09:00 and 17:00 h. The experimental
protocol was approved by the Institutional Animal Ethics
Committee (IAEC) of IASST, Guwahati (IASST/IAEC/2014-
15/751) and performed by following the guidelines of Committee
for Control and Supervision of Experimentation on Animals
(CPCSEA). Diabetes was induced in overnight fasted animals by
single intraperitoneal injection of freshly prepared streptozotocin
(STZ) in citrate buffer (pH: 4.5) at 55 mg/kg. Animals injected
with citrate buffer alone considered as control animals. Two
percent glucose solution (2 ml/kg) fed to all the animals before
STZ injection and diabetes confirmed by measuring the fasting
blood glucose (FBG) levels after 5 days of injection. Animals had
FBG levels more than 250 mg/dl is considered as diabetic and
included in the study (Kalita H. et al., 2016). Body weight and
FBG levels were measured every week throughout the study.
Experimental Protocol for Diabetic
Neuropathy
From the in vitro study results, A. reticulata and Z. jujuba
methanol extracts (ARBME and ZJME) and its water fractions
(ARBWF and ZJWF) were selected for in vivo assays. These
extracts and fractions were administered separately along with
insulin to evaluate against DNP. A total of 72 animals were
divided into twelve groups (n = 6). Animal’s response to
different analgesic models before STZ injection was recorded and
considered as 0th week reading. After STZ induction animals
left untreated for 4 weeks to precipitate diabetic neuropathic
condition and from the starting of 5th week, drug treatment
schedule started as follows:
Group-I: Normal animals + vehicle treatment (0.3%
carboxymethyl cellulose (CMC) orally).
Group-II: Animals with diabetes + vehicle treatment (0.3%
CMC orally).
Group-III: Animals with diabetes+ Insulin (5 IU/kg s.c.).
Group-IV: Animals with diabetes + Insulin (5 IU/kg s.c.) +
Pregabalin (100 mg/kg orally).
Group-V and VI: Animals with diabetes + Insulin (5 IU/kg
s.c.) + Oral gavage of ARBME (200 mg/kg) and ARBME (400
mg/kg).
Group-VII and VIII: Animals with diabetes + Insulin (5
IU/kg s.c.) + Oral gavage of ARBWF (50 mg/kg) and ARBWF
(100 mg/kg).
Group-XI and X: Animals with diabetes + Insulin (5 IU/kg
s.c.)+ Oral gavage of ZJME (200 mg/kg) and ZJME (400 mg/kg)
respectively.
Group-XI and XII: Animals with diabetes+ Insulin (5 IU/kg
s.c.) + Oral gavage of ZJWF (50 mg/kg) and ZJWF (100 mg/kg)
respectively.
Note: Plant extracts and fractions were suspended in 0.3%
CMC and fed the rats through oral gavage. Insulin injected
through subcutaneous route.
Behavioral assessments like thermal and mechanical
hyperalgesia were performed on 0th, 4th, 6th, and 8th week of
the study. At the end of the 8th week, animals in all the groups
were sacrificed by inhalation anesthesia to collect sciatic nerve
and stored in liquid nitrogen for biochemical estimation (SOD,
CAT, LPO, GSH, IL-1β, IL-6, IL-10, and TNF-α).
Behavioral Assessment
Hot Plate Test (Thermal Hyperalgesia)
Animals from all the groups were placed individually on Eddy’s
hot plate (55 ± 1◦C). The first sight of paw licking and jumping
was considered as escape latency and measured in seconds. To
avoid the damage to the animal paw, cut-off time was set to be
10 s (Salat et al., 2014).
Tail Immersion Test (Thermal Hyperalgesia)
The lower portion of the tail tip (5 cm) wasmarked and immersed
in the hot water (52.5 ± 1◦C). The tail withdrawal latency was
recorded in seconds and the test was repeated three times with
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at least 15 min interval. Cut-off time was set to be 15 s (Sharma
et al., 2006).
Cold Plate Test (Thermal Allodynia)
Animals were kept on the ice platform submerged about 1
cm below the surface of the chilled water (4◦C), such that
glabrous skin of animal feet in contact with the chilled water.
The escape latency time was recorded with the cutoff time 30 s
(Ranjithkumar et al., 2013).
Randall-Selitto Test (Mechanical Hyperalgesia)
The nociceptive threshold of the animals was measured following
Randall and Selitto procedure. Animals were habituated to the
laboratory environment before 1 h of the experiment with water
and food being withdrawn. Nociceptive threshold was measured
in grams by Randall-Selitto pressure analgesia meter (Panlab
Harvard Apparatus, Spain). Pressure on the paw was increasing
continuously until the animal was withdrawn the paw. To
prevent the damage to the paw, cutoff point was set to be 300 g.
Measurement of % Response of Various Treatments
against DNP in All Pain Models
After 8 weeks of drug treatment period the percentage response
of each drug treatment with respective to non-treatment in
various pain models (hot plate, tail immersion, cold plate and
paw pressure) were calculated by the following formula:
Response =
8th week drug treatment group reading
− 8th week vehicle treatment group reading
8th week vehicle treatment group reading
×100
(1)
8th week drug treatment group reading: Pain evaluation readings
at 8th week of diabetic animals treated with insulin (5 IU/kg), and
pregabalin (100 mg/kg), ARBME (200 and 400 mg/kg), ARBWF
(50 and 100 mg/kg), ZJME (200 and 400mg/kg), and ZJWF (50
and 100 mg/kg) treatments along with insulin (5 IU/kg).
8th week vehicle treatment group reading: Pain evaluation
readings at 8th week of diabetic animals treated with vehicle
(2ml/kg) alone.
Estimation of Biochemical Parameters
Tissue Collection and Lysate Preparation
At the end of the 8th week of drug treatment, all the animals
were sacrificed and whole sciatic nerve was isolated immediately
in liquid nitrogen and carried to laboratory from animal house.
Sciatic nerve homogenate (10% w/v) was prepared with 0.1
M Tris-HCl buffer (pH 7.4). Homogenates were centrifuged at
10K rpm for 15 min (4◦C) and the supernatant was collected
separately for biochemical estimation (Naik et al., 2006).
Determination of Antioxidant Enzymes and Lipid
Peroxidation
Supernatant was employed to estimate SOD and catalase
(CAT), from biochemical kits from Sigma-Aldrich according to
the protocol given by the manufacturer. Reduced glutathione
(GSH) levels were measured by following Kandimalla et al.
(2016c). Lipid peroxidation was determined by measuring the
thiobarbituric acid reactive substances (TBARS) (Ohkawa et al.,
1979).
Determination of Cytokine Levels
Levels IL-1β, IL-6, IL-10, and TNF-α, were determined by kits
available from RandD systems, USA as per the instructions given
by the manufacturer (Kandimalla et al., 2016c,d; Kalita et al.,
2017).
Western Blot Analysis to Measure NF-κB and iNOS
Expression
Sciatic nerve was homogenized with lysis buffer containing
protease inhibitors 1 mg/ml leupeptin, 1 mg/ml aprotinin, 1%
Triton X-100, 1 mM EDTA, 150 mM NaCl, 2.5 mM sodium
pyrophosphate, 1 mM Na3VO4, 1 mM b-glycerophosphate, and
20 mM Tris (pH 7.5) to obtain the protein lysate. Protein
separation was done by SDS-PAGE by loading equal quantity
of total protein in each well. Further, protein bands were
transferred to nitrocellulose membrane (Cell Signaling, USA).
Non-specific proteins were blocked by 5% fat-free milk powder,
and membranes were incubated with primary antibody NF-κB
and iNOS (1: 1,000) (Cell Signaling Technology, USA) separately
for 12 h at 4◦C.Membranes were washed with washing buffer and
incubated with horseradish peroxidase secondary antibody (1:
20,00). Bands were visualized under Chemidoc system (BioRad,
USA) using ECL kit (BioRad, USA). β-actin expression was also
measured to confirm the equal loading of the protein.
Statistical Analysis
All the results were expressed in mean± standard deviation. One
way ANOVA followed by Bonferroni post-hoc test was performed
to find the significant difference between the treatment groups. A
p ≤ 0.05 was considered as significant. All the statistical analysis
carried out in this study was done with GraphPad Prism 6
software.
RESULTS
Neuroprotective Effect of A. reticulata and
Z. jujuba Fractions on SHSY5Y cells
We have evaluated the effect of DMSO, H2O2 and all the plant
fractions on the cell viability of SHSY5Y cells. The results showed
that DMSO and plant fractions at tested concentrations did
not affect the cell viability of SHSY5Y cells. H2O2 treatment at
100 µM concentration significantly decreases the cell viability
to 64% compared to control group. This result indicates that
H2O2 causes potential damage to neuron cells. Bioactive fractions
of ARB and ZJ- Hexane (ARBHF and ZJHF), chloroform
(ARBCF and ZJCF), ethyl acetate (ARBEAF and ZJEAF) and
methanol residue (ARBMR and ZJMR) did not exhibited
significant protection from H2O2 toxicity. Whereas methanol
extract (ARBME and ZJME) and its water fraction (ARBWF and
ZJWF) showed significant (p≤ 0.05) protection from H2O2 dose
dependently (Table 1). Neuroprotection by these fractions were
further confirmed by the LDH and TBARS levels measurement.
H2O2 treatment leads to significant increase in the TBARS levels
and LDH leakage from the SHSY5Y cells into the culture media.
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TABLE 1 | Protective effect of A. reticulata and Z. jujuba plant extracts and fractions against H2O2 intoxicated SHSY5Y cell lines.
Group no. Treatment Concentration % Cell viability LDH (U/L) TBARS (nmol/mg protein)
Group-I (Control) Normal No treatment 98.5 ± 1.84 84.6 ± 0.94 1.84 ± 0.08
DMSO 0.25% V/V 97.8 ± 2.12 85.7 ± 1.03 1.87 ± 0.07
ARBME 200 µg/ml 96.8 ± 1.73 86.2 ± 0.82 1.86 ± 0.07
ARBHF 200 µg/ml 96.5 ± 1.66 85.4 ± 0.97 1.78 ± 0.08
ARBCF 200 µg/ml 96.7 ± 2.03 86.6 ± 1.12 1.81 ± 0.07
ARBEAF 200 µg/ml 96.2 ± 1.85 85.2 ± 1.07 1.89 ± 0.09
ARBWF 200 µg/ml 96.4 ± 1.92 86.8 ± 0.96 1.86 ± 0.08
ARBMR 200 µg/ml 96.7 ± 1.64 85.6 ± 0.81 1.82 ± 0.07
ZJME 200 µg/ml 97.1 ± 2.16 85.2 ± 0.88 1.79 ± 0.08
ZJHF 200 µg/ml 96.7 ± 1.78 85.6 ± 0.96 1.88 ± 0.09
ZJCF 200 µg/ml 96.4 ± 1.46 86.1 ± 1.14 1.85 ± 0.08
ZJEAF 200 µg/ml 97.3 ± 2.07 85.7 ± 0.86 1.87 ± 0.09
ZJWF 200 µg/ml 96.8 ± 1.62 86.8 ± 0.95 1.83 ± 0.07
ZJMR 200 µg/ml 96.6 ± 2.15 85.8 ± 1.12 1.78 ± 0.08
Group-II H2O2 control 100 µM 38.7 ± 2.73ˆ 157.9 ± 4.26ˆ 4.28 ± 0.24ˆ
Group-III ARBME + H2O2 50 µg/ml + 100 µM 69.2 ± 3.47* 117.4 ± 3.16* 2.97 ± 0.17*
100 µg/ml + 100 µM 76.4 ± 3.82* 106.8 ± 2.68* 2.53 ± 0.15*
200 µg/ml + 100 µM 84.6 ± 3.25*# 94.2 ± 2.19*# 2.18 ± 0.11*#
ARBHF + H2O2 50 µg/ml + 100 µM 41.2 ± 2.81 152.4 ± 3.62 4.12 ± 0.21
100 µg/ml + 100 µM 43.6 ± 2.64 151.7 ± 3.85 4.06 ± 0.23
200 µg/ml + 100 µM 43.9 ± 3.54 150.5 ± 4.16 4.04 ± 0.21
ARBCF + H2O2 50 µg/ml + 100 µM 39.5 ± 3.17 157.2 ± 4.07 4.15 ± 0.26
100 µg/ml + 100 µM 40.8 ± 2.62 155.2 ± 3.42 4.11 ± 0.23
200 µg/ml + 100 µM 41.7 ± 2.86 152.8 ± 4.21 4.08 ± 0.19
ARBEAF + H2O2 50 µg/ml + 100 µM 40.4 ± 3.45 156.7 ± 3.27 4.09 ± 0.22
100 µg/ml + 100 µM 41.8 ± 2.69 153.5 ± 4.11 4.08 ± 0.25
200 µg/ml + 100 µM 42.6 ± 3.14 152.1 ± 3.68 4.02 ± 0.19
ARBWF + H2O2 50 µg/ml + 100 µM 78.6 ± 3.86* 104.8 ± 2.59* 2.56 ± 0.11*
100 µg/ml + 100 µM 86.2 ± 4.17* 90.7 ± 2.81* 2.21 ± 0.13*
200 µg/ml + 100 µM 92.1 ± 3.66*# 88.2 ± 2.44*# 2.02 ± 0.09*#
ARBMR + H2O2 50 µg/ml + 100 µM 44.5 ± 3.92 142.6 ± 3.27 3.46 ± 0.17
100 µg/ml + 100 µM 49.8 ± 2.73 137.8 ± 3.41 3.24 ± 0.18
200 µg/ml + 100 µM 55.3 ± 4.14* 131.2 ± 2.85* 3.11 ± 0.16*
Group-IV ZJME + H2O2 50 µg/ml + 100 µM 72.8 ± 4.27* 114.3 ± 3.62* 2.72 ± 0.19*
100 µg/ml + 100 µM 79.6 ± 3.62* 102.6 ± 3.05*# 2.44 ± 0.14*
200 µg/ml + 100 µM 88.5 ± 4.08*# 89.7 ± 2.43*# 2.07 ± 0.12*#
ZJHF + H2O2 50 µg/ml + 100 µM 40.8 ± 3.48 155.2 ± 4.16 4.02 ± 0.19
100 µg/ml + 100 µM 41.2 ± 2.86 152.8 ± 3.45 3.97 ± 0.21
200 µg/ml + 100 µM 41.8 ± 3.16 151.9 ± 4.21 3.92 ± 0.18
ZJCF + H2O2 50 µg/ml + 100 µM 39.2 ± 2.44 158.2 ± 3.86 4.07 ± 0.23
100 µg/ml + 100 µM 40.3 ± 3.24 156.4 ± 4.08 4.01 ± 0.17
200 µg/ml + 100 µM 41.1 ± 2.61 154.3 ± 3.58 3.95 ± 0.19
ZJEAF + H2O2 50 µg/ml + 100 µM 43.7 ± 2.54 149.6 ± 2.96 4.03 ± 0.19
100 µg/ml + 100 µM 44.2 ± 3.16 148.2 ± 3.38 3.94 ± 0.21
200 µg/ml + 100 µM 44.9 ± 3.32 147.1 ± 3.02 3.88 ± 0.21
ZJWF + H2O2 50 µg/ml + 100 µM 80.7 ± 4.38* 101.7 ± 2.47* 2.41 ± 0.14*
100 µg/ml + 100 µM 89.6 ± 4.72* 88.1 ± 2.13*# 2.08 ± 0.11*
200 µg/ml + 100 µM 94.7 ± 5.16*# 86.8 ± 2.26*# 1.91 ± 0.08*#
(Continued)
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TABLE 1 | Continued
Group no. Treatment Concentration % Cell viability LDH (U/L) TBARS (nmol/mg protein)
ZJMR + H2O2 50 µg/ml + 100 µM 42.4 ± 4.11 150.6 ± 3.11 3.73 ± 0.22
100 µg/ml + 100 µM 43.5 ± 3.78 149.2 ± 2.94 3.59 ± 0.17
200 µg/ml + 100 µM 44.7 ± 3.21 148.4 ± 3.01 3.45 ± 0.19
All the results were presented in mean ± S.D (n = 5). ˆp ≤ 0.05 in comparison of toxin treated control group (Group-II) with normal control. *p ≤ 0.05 in comparison of group-III and IV
with group-II. #p ≤ 0.05 in comparison between the different doses of same treatment. ARBME: A. reticulata bark methanol extract; ARBHF, A. reticulata bark hexane fraction; ARBCF,
A. reticulata bark chloroform fraction; ARBEAF, A. reticulata bark ethyl acetate fraction; ARBWF, A. reticulata bark water fraction; ARBMR, A. reticulata bark methanol residue. ZJME,
Z. jujuba root bark methanol extract; ZJHF, Z. jujuba root bark hexane fraction; ZJCF, Z. jujuba root bark chloroform fraction; ZJEAF, Z. jujuba root bark ethyl acetate fraction; ZJWF, Z.
jujuba root bark water fraction; ZJMR, Z. jujuba root bark methanol residue.
Whereas cells pretreated with ARBME, ARBWF, ZJME, and
ZJWF showed less levels of TBARS and LDH leakage. LDH
assay and TBARS results further strengthen the neuroprotective
ability of the plant fractions. Among all the fractions tested water
fractions (ARBWF and ZJWF) of both the plants were found to
be potent than the methanol extracts (ARBME and ZJME). From
these in vitro results, ARBME, ZJME, ARBWF, and ZJWF were
selected for further evaluation using animal models.
Neuroprotective Effect of A. reticulata and
Z. jujuba Active Fractions on DRG
Neuronal Cells
MTT assay results depicted that H2O2 (100 µM) caused
significant (p≤ 0.05) decline in the cell viability of DRG neurons
compared to normal control. DMSO (0.1% v/v), ARBME,
ARBWF, ZJME, and ZJWF at 200 µg/ml did not showed
adverse effect on cell viability. Further DRG cells pre-treated
with ARBME, ARBWF, ZJME, and ZJWF showed significant
neuroprotection (p ≤ 0.05) from H2O2 in a dose dependent
manner compared to H2O2 alone treated cells (Table 2).
Acute Toxicity Studies
All the tested fractions (ARBME, ARBWF, ZJME, and ZJWF)
at 2,000 mg/kg and same fractions along with insulin (5 IU/kg)
did not show any effect on heart rate, respiratory rate, corneal
reflex, body temperature, salivation, locomotor activity, skin
tone, body tone, abdominal tone, grip strength, tremors, tail
elevation, piloerection, twitches, and convulsions. During 14
days of the observation period, no mortality was observed in
extract treated animals. Acute toxicity study results conclude
that ARBME, ARBWF, ZJME, and ZJWF were non-toxic to the
animals at tested concentration. So we further continued the
in vivo experiments on these plant fractions against diabetic
neuropathy.
Effect of Different Drug Treatment on Body
Weight and Fasting Blood Glucose
Diabetic animals treated with vehicle (2 ml/kg) showed
significant (p ≤ 0.05) decline in body weight at 8th week
compared with sham control group 8th week. Where there was
no significant difference in body weight was observed in animals
treated pregabalin (100 mg/kg), ARBME (200 and 400 mg/kg),
ARBWF (50 and 100 mg/kg), ZJME (200 and 400 mg/kg), ZJWF
(50 and 100 mg/kg) treatments along with insulin (5 IU/kg) at
TABLE 2 | Protective effect of A. reticulata and Z. jujuba active plant
fractions against H2O2 intoxicated DRG neuronal cells.
Group no. Treatment Concentration % Cell viability
Group-I (Control) Normal No treatment 99.2 ± 3.26
DMSO 0.1% V/V 98.5 ± 3.78
ARBME 200 µg/ml 98.7 ± 3.18
ARBWF 200 µg/ml 98.1 ± 2.94
ZJME 200 µg/ml 98.3 ± 3.41
ZJWF 200 µg/ml 97.8 ± 3.08
Group-II H2O2 control 100 µM 51.3 ± 4.73ˆ
Group-III ARBME + H2O2 50 µg/ml + 100 µM 72.6 ± 5.13*
100 µg/ml + 100 µM 81.8 ± 4.84*
200 µg/ml + 100 µM 87.1 ± 4.63*
ARBWF + H2O2 50 µg/ml + 100 µM 76.9 ± 4.38*
100 µg/ml + 100 µM 85.2 ± 3.94*
200 µg/ml + 100 µM 89.5 ± 4.46*
Group-IV ZJME + H2O2 50 µg/ml + 100 µM 74.8 ± 3.88*
100 µg/ml + 100 µM 81.1 ± 5.07*
200 µg/ml + 100 µM 88.6 ± 4.27*
ZJWF + H2O2 50 µg/ml + 100 µM 79.4 ± 5.16*
100 µg/ml + 100 µM 87.3 ± 4.48*
200 µg/ml + 100 µM 92.5 ± 3.69*
All the results were presented in mean ± S.D (n = 5). ˆp ≤ 0.05 in comparison of toxin
treated control group (Group-II) with normal control. *p ≤ 0.05 in comparison of group-III
and IV with group-II. ARBME, A. reticulata bark methanol extract; ARBWF, A. reticulata
bark water fraction; ZJME, Z. jujuba root bark methanol extract; ZJWF, Z. jujuba root bark
water fraction.
8th week compared with insulin (5 IU/kg) alone treated animals.
STZ (50 mg/kg) treatment causes significant (p ≤ 0.05) rise in
FBG levels of all treatment groups at 1st week. Further, treatment
with insulin (5 IU/kg) alone causes a significant (p≤ 0.05) decline
in the FBG levels at 8th week compared to diabetic control
at 8th week. Further standard drug pregabalin (100 mg/kg),
ARBME (200mg and 400 mg/kg), ARBWF (50 mg/kg), ZJME
(200 mg/kg), and ZJWF (50 mg/kg) treatment along with insulin
did not decrease the FBG levels significantly compared to insulin
alone treated group. However, ZJME at 400 mg/kg, ARBWF and
ZJWF at 100 mg/kg treatment along with insulin cause further
significant (p≤ 0.05) reduction in FBG levels compared to insulin
alone treated animals (Table 3).
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TABLE 3 | Effect of different drug treatment on body weight and blood glucose at different intervals.
Group Treatment Body weight (gm) FBG (mg/dl)
0th week 1st week 8th week 0th week 1st week 8th week
I Normal animals (Sham control) 225.8 ± 8.1 226.2 ± 8.2 229.4 ± 7.9 98.1 ± 8.8 97.8 ± 8.6 98.3 ± 7.2
II Diabetic control 224.9 ± 7.2 224.5 ± 7.4 194.7 ± 9.2ˆ 96.4 ± 7.5 294.8 ± 17.8 346.2 ± 27.4ˆ
III Diabetic animals + Insulin (5 IU/kg) 222.5 ± 8.4 221.8 ± 8.6 217.5 ± 7.9 101.2 ± 6.9 284.5 ± 21.6 132.7 ± 14.8*
IV Diabetic animals+ Pregabalin (100 mg/kg)+ Insulin (5 IU/kg) 226.2 ± 9.4 225.7 ± 9.6 219.2 ± 7.5 98.7 ± 6.8 289.4 ± 24.8 137.2 ± 16.4*
V Diabetic animals+ ARBME (200 mg/kg)+ Insulin (5 IU/kg) 223.8 ± 6.6 223.2 ± 6.8 216.8 ± 8.4 100.6 ± 7.4 275.9 ± 18.4 126.5 ± 14.3*
VI Diabetic animals+ ARBME (400 mg/kg)+ Insulin (5 IU/kg) 226.3 ± 7.9 225.7 ± 8.1 214.8 ± 9.3 97.5 ± 6.7 296.7 ± 22.4 115.8 ± 13.6*
VII Diabetic animals+ ARBWF (50 mg/kg) Insulin+ (5 IU/kg) 223.4 ± 7.8 222.8 ± 7.6 214.3 ± 6.2 101.8 ± 8.2 272.6 ± 26.1 122.9 ± 14.3*
VIII Diabetic animals+ ARBWF (100 mg/kg)+ Insulin (5 IU/kg) 226.9 ± 9.9 226.5 ± 10.3 217.6 ± 7.7 98.6 ± 7.3 294.3 ± 18.3 107.5 ± 10.9*$
IX Diabetic animals+ ZJME (200 mg/kg)+ Insulin (5 IU/kg) 226.3 ± 8.5 225.9 ± 8.3 215.2 ± 8.6 99.4 ± 8.4 277.4 ± 20.6 131.2 ± 14.6*
X Diabetic animals+ ZJME (400 mg/kg)+ Insulin (5 IU/kg) 224.1 ± 9.3 223.6 ± 9.5 214.7 ± 6.8 101.2 ± 8.1 295.2 ± 16.8 109.6 ± 13.7*$#
XI Diabetic animals+ ZJWF (50 mg/kg)+ Insulin (5 IU/kg) 224.9 ± 10.2 224.3 ± 10.6 217.8 ± 7.9 97.7 ± 7.5 276.1 ± 27.5 124.8 ± 16.3*
XII Diabetic animals+ ZJWF (100 mg/kg)+ Insulin (5 IU/kg) 226.6 ± 9.6 226.3 ± 9.8 216.4 ± 10.2 96.5 ± 7.2 284.9 ± 21.4 103.6 ± 12.8*$#
All the results were presented in mean ± S.D (n = 6). ˆp ≤ 0.05 in comparison of diabetic animals (Group-II) with normal animals (Group-I). *p ≤ 0.05 in comparison of drug treated
groups (Group: III–XII) with diabetic control group (Group: II). $p ≤ 0.05 in comparison of drug treatment along with insulin treated groups (Group: IV–XII) with insulin alone treated group
(Group-III). #p ≤ 0.05 in comparison between the different doses of same treatment groups. ARBME, A. reticulata bark methanol extract; ARBWF, A. reticulata bark water fraction;
ZJME, Z. jujuba root bark methanol extract; ZJWF, Z. jujuba root bark water fraction.
Effect of Different Drug Treatment on
Behavioral Parameters
Thermal Hyperalgesia (Hot Plate and Tail Immersion
Tests)
A significant decrease (p ≤ 0.05) in the escape latency period
was observed at 4th week in diabetes induced animals compared
to the 0th week. This decrease was consistent up to 8th week
in vehicle (2 ml/kg) alone treated animals. Where as in sham
control group there was no significant difference in the escape
latency period was observed. Insulin (5 IU/kg) treatment alone
fails to improve this condition as no significant difference in
escape latency period was observed at 6th and 8th week compared
with 4th week. Further pregabalin (100 mg/kg), ARBME (200
and 400 mg/kg), ARBWF (50 and 100 mg/kg), ZJME (200 and
400 mg/kg), and ZJWF (50 and 100 mg/kg) along with insulin
(5 IU/kg) decreases the thermal hyperalgesia, where a significant
(p ≤ 0.05) increase in escape latency period was observed at 6th
and 8th week of treatment compared with 4th week. We also
observed a significant increase in escape latency period at 6th and
8th week compared with 6th and 8th week escape latency period
of insulin alone treated animals respectively (Figures 2, 3).
Thermal Allodynia (Cold Plate Test)
Diabetes induced animals showed significant (p ≤ 0.05) decrease
in escape latency period at 4th week compared to 0th week
response; this decline was maintained until the end of the
study (8th week) in vehicle alone treated animals. Whereas in
sham control group there was no significant changes observed
throughout the study. Pregabalin (100 mg/kg), ARBME (200
and 400 mg/kg), ARBWF (50 and 100 mg/kg), ZJME (200 and
400 mg/kg), and ZJWF (50 and 100 mg/kg) treatments along
with insulin (5 IU/kg) cause significant increase (p ≤ 0.05) in
escape latency period at 6th and 8th week compared to 4th week
response. In this study even insulin (5 IU/kg) treatment alone
causes reversal of cold allodynia at 6th and 8th week significantly
(p ≤ 0.05) compared with 4th week (Figure 4). In this test
ARBME, ZJME, ARBWF, and ZJWF at tested high dose resulted
in complete reversal of allodynia.
Mechanical Hyperalgesia (Randall-Selitto Test)
Results of mechanical hyperalgesia reveals that diabetic animals
produce significant (p ≤ 0.05) decrease in paw withdrawal
threshold at 4th week compared to 0th week basal value.
Consistent declaim was observed in vehicle alone treated
animals. No significant difference was observed at different
weeks in animals of sham control group. Insulin (5 IU/kg) alone
treated diabetic animals were showed no recovery from this
condition at 6th and 8th week of treatment. However, Pregabalin
(100 mg/kg), ARBME (200 and 400 mg/kg), ARBWF (50 and 100
mg/kg), ZJME (200 and 400 mg/kg), and ZJWF (50 and 100
mg/kg) treatments along with insulin (5 IU/kg) potentially
increase the paw withdrawal threshold at 6th and 8th week
compared to 4th week. We have further observed a significant
(p ≤ 0.05) increase in paw withdrawal threshold at 6th and
8th week compared with 6th and 8th week paw withdrawal
threshold of insulin alone treated animals respectively
(Figure 5).
% Response of Various Treatments against DNP in All
Pain Models
Figure 6 represents the % response of various drug treatments in
different pain models of DNP. Animals treated with pregabalin
(100 mg/kg), ARBME (200 and 400 mg/kg), ARBWF (50 and
100 mg/kg), ZJME (200 and 400 mg/kg), and ZJWF (50 and
100 mg/kg) along with insulin (5 IU/kg) showed significant
(p ≤ 0.05) increase in the % response compared to insulin (5
IU/kg) alone treated animals in hot plate, tail immersion and
Randall-Selitto tests. But in cold plate measurement; only ZJME
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FIGURE 2 | Effect of different drug treatment on thermal hyperalgesia induced by hot plate method in diabetic neuropathic animals at different time
intervals. All the results were expressed in mean ± S.D (n = 6). ∧ is p ≤ 0.05 in comparison of 4th week with 0th week. * is p ≤ 0.05 in comparison of 6th and 8th
week with 4th week. $ is p ≤ 0.05 in comparison with insulin alone treated diabetic group at corresponding weeks. ARBME, A. reticulata bark methanol extract;
ARBWF, A. reticulata bark water fraction; ZJME, Z. jujuba root bark methanol extract; ZJWF, Z. jujuba root bark water fraction.
FIGURE 3 | Effect of different drug treatment on thermal hyperalgesia induced by tail immersion method in diabetic neuropathic animals at different
time intervals. All the results were expressed in mean ± S.D (n = 6). ∧ is p ≤ 0.05 in comparison of 4th week with 0th week. * is p ≤ 0.05 in comparison of 6th and
8th week with 4th week. $ is p ≤ 0.05 in comparison with insulin alone treated diabetic group at corresponding weeks. ARBME, A. reticulata bark methanol extract;
ARBWF, A. reticulata bark water fraction; ZJME, Z. jujuba root bark methanol extract; ZJWF, Z. jujuba root bark water fraction.
(400 mg/kg), ARBWF (100 mg/kg), and ZJWF (100 mg/kg)
along with insulin (5 IU/kg), showed significant difference in
% response compared to insulin (5 IU/kg) alone treatment
group.
Effect of Drug Treatment on Lipid Peroxidation
A significant (p ≤ 0.05) increase in the LPO was observed
in diabetic animals compared to non-diabetic animals (Sham
control). Insulin (5 IU/kg) along with pregabalin (100 mg/kg),
ARBME (200 and 400 mg/kg), ARBWF (50 and 100 mg/kg),
ZJME (200 and 400 mg/kg), and ZJWF (50 and 100 mg/kg)
treatment significantly (p ≤ 0.05) decrease d the LPO levels
compared to diabetic animals. Where insulin (5 IU/kg) treatment
alone fails to significantly lowering down the LPO levels than
diabetic control. Further, except pregabalin (100mg/kg), ARBME
(200 mg/kg) along with Insulin (5 IU/kg) all the other drug
treatment groups showed significantly (p ≤ 0.05) less levels
of LPO compared to insulin (5 IU/kg) alone treated animals.
ARBWF and ZJWF at both the doses showed strong response
than ARBME and ZJME (Table 4).
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FIGURE 4 | Effect of different drug treatment on thermal allodynia induced by cold plate method in diabetic neuropathic animals at different time
intervals. All the results were expressed in mean ± S.D (n = 6). ∧ is p ≤ 0.05 in comparison of 4th week with 0th week. * is p ≤ 0.05 in comparison of 6th and 8th
week with 4th week. $ is p ≤ 0.05 in comparison with insulin alone treated diabetic group at corresponding weeks. ARBME, A. reticulata bark methanol extract;
ARBWF, A. reticulata bark water fraction; ZJME, Z. jujuba root bark methanol extract; ZJWF, Z. jujuba root bark water fraction.
FIGURE 5 | Effect of different drug treatment on mechanical hyperalgesia induced by paw pressure analgesiometer method in diabetic neuropathic
animals at different time intervals. All the results were expressed in mean ± S.D (n = 6). ∧ is p ≤ 0.05 in comparison of 4th week with 0th week. * is p ≤ 0.05 in
comparison of 6th and 8th week with 4th week. $ is p ≤ 0.05 in comparison with insulin alone treated diabetic group at corresponding weeks. ARBME, A. reticulata
bark methanol extract; ARBWF, A. reticulata bark water fraction; ZJME, Z. jujuba root bark methanol extract; ZJWF, Z. jujuba root bark water fraction.
Effect of Drug Treatment on Antioxidant Enzyme
Levels
Diabetic animals showed a significant (p ≤ 0.05) decrease in
antioxidant enzymes SOD, CAT and GSH compared to normal
animals. A significant (p ≤ 0.05) increase in all the tested
antioxidant enzymes (SOD, CAT and GSH) was observed in
diabetic animals treated with ARBME (200 and 400 mg/kg),
ZJME (200 and 400 mg/kg), ARBWF (50 and 100 mg/kg), ZJWF
(50 and 100 mg/kg), and pregabalin (100 mg/kg) treatment
along with insulin (5 IU/kg) compared to vehicle treated diabetic
animals. Insulin (5 IU/kg) alone treated animals also showed
a significant (p ≤ 0.05) rise in SOD and GSH levels but
not CAT when compared to vehicle treated diabetic animals.
Further, treatment with pregabalin (100 mg/kg), ARBME (400
mg/kg), ARBWF (100 mg/kg), ZJME (400 mg/kg), ZJWF (50 and
100mg/kg) along with insulin (5 IU/kg) showed significant (p
≤ 0.05) increase in SOD levels compared to insulin (5 IU/kg)
alone treated diabetic animals. In case of CAT levels, apart
from ARBWF and ZJWF at 100mg/kg along with insulin (5
IU/kg) no other treatment groups showed significant difference
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FIGURE 6 | Effect of different drug treatments on % response in various pain models. (A) Insulin (5 IU/kg); (B) Pregabalin (100 mg/kg) + Insulin (5 IU/kg); (C)
ARBME (200 mg/kg) + Insulin (5 IU/kg); (D) ARBME (400 mg/kg) + Insulin (5 IU/kg); (E) ARBWF (50 mg/kg) + Insulin (5 IU/kg); (F) ARBWF (100 mg/kg) + Insulin (5
IU/kg); (G) ZJME (200 mg/kg) + Insulin (5 IU/kg); (H) ZJME (400 mg/kg) + Insulin (5 IU/kg); (I) ZJWF (50 mg/kg) + Insulin (5 IU/kg); (J) ZJWF (100 mg/kg) + Insulin (5
IU/kg). All the results were expressed in mean ± S.D. * is p ≤ 0.05 in comparison of (B–J) with (A).
TABLE 4 | Effect of drug treatment on sciatic nerve lipid peroxidation and antioxidant enzyme levels.
Group No. Group SOD (U/ml) CAT (nmol/min/ml) GSH (nm/mg protein) TBARS (nmol/g tissue)
I Normal animal (Sham control) 11.8 ± 1.9 6.8 ± 0.7 9.7 ± 0.92 143.8 ± 7.4
II Diabetic control 3.2 ± 0.9ˆ 1.8 ± 0.4ˆ 2.4 ± 0.47ˆ 317.6 ± 14.8ˆ
III Diabetic animals + Insulin (5 IU/kg) 5.1 ± 1.2* 3.2 ± 0.6 4.2 ± 0.64* 266.4 ± 16.3
IV Diabetic animals+ Pregabalin (100 mg/kg)+ Insulin (5 IU/kg) 7.6 ± 1.7*$ 3.9 ± 1.1* 5.9 ± 0.75*$ 248.7 ± 13.4*
V Diabetic animals+ ARBME (200 mg/kg)+ Insulin (5 IU/kg) 6.3 ± 1.1* 4.1 ± 0.8* 5.1 ± 0.68* 241.5 ± 12.7*
VI Diabetic animals+ ARBME (400 mg/kg)+ Insulin (5 IU/kg) 7.7 ± 1.4*$ 4.6 ± 0.7* 6.5 ± 0.73*$ 219.6 ± 14.6*$#
VII Diabetic animals+ ARBWF (50 mg/kg) Insulin+ (5 IU/kg) 7.1 ± 1.7* 4.4 ± 0.9* 6.2 ± 0.59*$ 227.5 ± 15.2*$
VIII Diabetic animals+ ARBWF (100 mg/kg)+ Insulin (5 IU/kg) 8.4 ± 1.5*$ 5.1 ± 1.1*$ 7.1 ± 0.84*$ 204.9 ± 12.3*$
IX Diabetic animals+ ZJME (200 mg/kg)+ Insulin (5 IU/kg) 6.5 ± 1.6* 4.3 ± 0.8* 5.3 ± 0.64* 233.1 ± 16.8*$
X Diabetic animals+ ZJME (400 mg/kg)+ Insulin (5 IU/kg) 7.9 ± 1.8*$ 4.8 ± 0.9* 6.9 ± 0.77*$# 211.6 ± 14.4*$#
XI Diabetic animals+ ZJWF (50 mg/kg)+ Insulin (5 IU/kg) 7.4 ± 1.4*$ 4.7 ± 1.3* 6.5 ± 0.71*$ 220.4 ± 12.3*$
XII Diabetic animals+ ZJWF (100 mg/kg)+ Insulin (5 IU/kg) 8.7 ± 1.7*$ 5.4 ± 1.2*$ 7.6 ± 0.87*$ 196.2 ± 16.6*$#
All the results were presented in mean ± S.D (n = 6). ˆp ≤ 0.05 in comparison of diabetic animals (Group-II) with normal animals (Group-I). *p ≤ 0.05 in comparison of drug treated
groups (Group-III–XII) with diabetic control group (Group-II). $p ≤ 0.05 in comparison of drug treatment along with insulin treated groups (Group-IV to XII) with insulin alone treated group
(Group-III). #p ≤ 0.05 in comparison between the different doses of same treatment. ARBME, A. reticulata bark methanol extract; ARBWF, A. reticulata bark water fraction; ZJME, Z.
jujuba root bark methanol extract; ZJWF, Z. jujuba root bark water fraction.
compared to insulin (5 IU/kg) alone treated diabetic animals.
Insulin (5 IU/kg) treatment along with ARBME and ZJME at
200mg/kg did not alter the GSH levels significantly compared
to insulin (5 IU/kg) alone treated animals whereas, all the other
drug treatments increased significantly (Table 4).
Effect of Drug Treatment on Cytokine Levels
At the end of the study, animals from all the treatment
groups were measured for cytokine levels. Animals in diabetic
control showed significant (p ≤ 0.05) increase in all the
inflammatory cytokines (IL-1β, IL-6, and TNF-α) and decrease
in anti-inflammatory cytokine (IL-10) compared to non-diabetic
animals (Sham control). Insulin (5 IU/kg) treatment alone failed
to improve this condition. Whereas, pregabalin (100 mg/kg),
ARBME (200 and 400 mg/kg), ARBWF (50 and 100 mg/kg),
ZJME (200 and 400mg/kg), and ZJWF (50 and 100 mg/kg)
treatment along with insulin (5 IU/kg) showed significant
(p ≤ 0.05) improvement in impaired levels of all the cytokines
compared to diabetic control and insulin (5 IU/kg) alone treated
diabetic animals. But, ARBME (200 mg/kg) and ZJME (200
mg/kg) along with insulin (5 IU/kg) did not alter the TNF-α
levels further compared to insulin (5 IU/kg) alone treated animals
(Figures 7A–D).
Effect of Drug Treatment on NF-κB and iNOS Protein
Expression
Increased expression of inflammatory cytokines is mediated by
NF-κB in diabetic neuropathic rats. So, in this present study
we measured the effect of plant fractions on NF-κB and iNOS
protein levels through western blotting analysis. The blot results
reveal that treatment with pregabalin (100 mg/kg), ARBME
(400 mg/kg), ZJME (400 mg/kg), ARBWF (100 mg/kg), and
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ZJWF (100 mg/kg) along with insulin (5 IU/kg) inhibits the
NF-κB and iNOS expression compared to diabetic animals.
Insulin (5 IU/kg) alone treated animals exhibited no difference
in these protein expression levels. Figure 8 explains the NF-
κB and iNOS expression in sciatic nerve of the animal from
different treatment groups. ARBWF and ZJWF at 100 mg/kg
along with insulin (5 IU/kg) treated animals showed better
response than animals treated with ARBME and ZJME at 400
mg/kg along with insulin (5 IU/kg). This result demonstrates that
polar chemical constituents of methanol extracts of A. reticulata
bark and Z. jujuba root bark play a significant role in controlling
inflammation mediated DNP.
DISCUSSION
In this present study, we evaluated neuroprotective effect of
bioactive guided fractions of A. reticulata bark and Z. jujuba root
bark against DNP. The neuroprotective ability of the different
plant fractions were tested against SHSY5Y neuroblastoma cell
lines. Among all the fractions tested ARBME, ARWF, ZJME,
and ZJWF showed neuroprotection against H2O2 induced
death of SHSY5Y cells. The results of MTT assay revealed
that H2O2 treatment cause significant decline in viability of
SHSY5Y cells. ARBME, ARWF, ZJME, and ZJWF at tested doses
attenuated the toxicity induced by H2O2 where a significant
increase in cell viability was observed in a dose-dependent
manner. H2O2 induced toxicity in SHSY5Y cells is a widely
used model to measure the neuroprotective ability of the
drugs/pharmaceuticals. H2O2 is a major ROS that penetrates
into the cells and produces highly reactive hydroxyl radicals
which involve in the induction of oxidative damage to cell
organelles including DNA, lipids, and proteins. This damage
leads to the decrease in the viability of the cells (Nirmaladevi
et al., 2014). H2O2 promotes LPO which intern damages the
cell membrane with subsequent LDH leakage and necrosis
(Garcimartin et al., 2014). LDH is a cytoplasmic enzyme that
found in almost all cells of the body. Leakage of the cytosolic
enzymes is considered as indication of oxidative stress induced
cell damage. H2O2 treatment caused a significant increase in
LPO and LDH leakage from SHSY5Y cell into the culture
media which is an indication of oxidative stress mediated cell
damage. SHSY5Y cell treated with ARBME, ARWF, ZJME, and
FIGURE 7 | Effect of different drug treatment on sciatic nerve (A) Interleukin-1β (B) Interleukin-6 (C) tumor necrosis factor-α and (D) Interleukin-10 levels in
diabetic neuropathic animals. All the results were expressed in mean ± S.D (n = 6). ∧ is p ≤ 0.05 in comparison with normal animals. * is p ≤ 0.05 in comparison with
vehicle treated diabetic animals. $ is p ≤ 0.05 in comparison with insulin alone treated diabetic group. ARBME, A. reticulata bark methanol extract; ARBWF, A.
reticulata bark water fraction; ZJME, Z. jujuba root bark methanol extract; ZJWF, Z. jujuba root bark water fraction.
FIGURE 8 | Effect of four week drug treatment on change in expression of NF-κB and iNOS measured by western blotting analysis. Equal loading was
confirmed by β-Actin expression. (1) Normal control (2) Diabetic animals with no treatment; (3) Diabetic animals treated with Insulin (5 IU/kg); (4) Diabetic animals
treated with pregabalin (100 mg/kg) + Insulin (5 IU/kg); (5) Diabetic animals treated with ARBME (400 mg/kg) + Insulin (5 IU/kg); (6) Diabetic animals treated with
ARBWF (100 mg/kg) + Insulin (5 IU/kg); (7) Diabetic animals treated with ZJME (400 mg/kg) + Insulin (5 IU/kg); (8) Diabetic animals treated with ZJWF (100 mg/kg) +
Insulin (5 IU/kg).
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ZJWF exhibited neuroprotection against H2O2 induced damage,
which was confirmed by increased cell viability, reduced LPO
and LDH leakage. This action was due to the neutralization of
peroxide radicles and decrease in membrane lipid peroxidation.
These active fractions could be translationable neuroprotective
agents which will help to prevent cell death under vulnerability
conditions related to excessive ROS production.
Relay of sensory information to the central nervous system
occurs through axons of DRG neurons. They are an experimental
target of diabetic neuropathy due to their exuberant metabolism
and sensitivity to high glycaemia. Even short term hyperglycemic
condition leads to DRG neurons oxidative damage and apoptosis.
In painful neuropathy inflammatory factors plays a crucial
role in DRG neuronal damage. Therefore, stabilizing oxidative
stress and inhibition of inflammation has been considered as
mainstream strategies for the treatment of DNP. As discussed
above H2O2 initiate oxidative damage to neuronal cells and
leads to cell death. In this study H2O2 produced significant
decline in cell viability of DRG neuronal cells. Due to
strong antioxidant ability; ARBME, ARWF, ZJME, and ZJWF
demonstrated significant neuroprotection toward H2O2 induced
neuronal damage in DRG cells. From the in vitro results, active
plant fractions (ARBME, ARWF, ZJME, and ZJWF) were selected
to continue the in vivo experiment.
STZ induced diabetic model is widely used to precipitate DNP
condition (He et al., 2016). In this present study, STZ induced
rats showed a significant increase in the FBG levels and decreased
nociceptive threshold. Pregabalin has been used as a standard
drug in this study which is a selective α2δ subunit of voltage-gated
calcium channels antagonist which is an anticonvulsant drug
can potentially inhibits the diabetic neuropathy. Diabetic animals
treated with pregabalin, ARBME, ARWF, ZJME, and ZJWF along
with insulin increased the nociceptive threshold, inhibited the
oxidative stress and inflammatory markers. Animals responded
to the hot plate test through paw licking and jumping, which
mediated through activation of supraspinal sensitive fibers type
I and II (Lopes et al., 2009). Endogenous release of tachykinin
neuropeptide substance P in the spinal cord involves in the
tail withdrawal due to thermal stimuli in tail immersion test
(Yashpal et al., 1993). Randall-Selitto test explains the mechanical
hyperalgesia response of the animals and the mechanism behind
this action is unclear (Srebro et al., 2015). ARBME, ARWF, ZJME,
and ZJWF along with insulin produce an antinociceptive effect
in diabetic animals with the neuropathic condition in the hot
plate, tail immersion, and paw pressure models, which explain
that all the plant fractions act through central mechanisms. This
antinociceptive response showed by the plant fractions was due
to inhibition of the oxidative stress and inflammatory markers.
A. reticulata and Z. jujuba different plant parts have been
reported previously for antinociceptive and antiinflammatory
activity (Mahajan and Chopda, 2009; Jamkhande et al., 2016).
In DN condition, cold allodynia precipitate due to loss of Aδ
fibers which lead to sensitization of cold receptors (Ranjithkumar
et al., 2013). Reports suggest that degeneration of the nerve
fibers occurs due to hyperglycemia mediated ischemia (Nukada,
2014). In this study insulin treatment alone showed reduction
in cold allodynia condition which might be linked to the
reduction of hyperglycemia. Similar results were reported by
the previous studies (Finnerup and Jensen, 2006; Casey et al.,
2010; Ranjithkumar et al., 2013). Supplement of pregabalin (100
mg/kg), ARWF and ZJWF (100mg/kg) along with insulin further
significantly decrease the allodynia condition. Results of cold
allodynia test reveal that polar chemical constitutes of ARB and
ZJ have the ability to treat this condition potentially.
Hyperglycemia leads to microvascular and macrovascular
complications in the diabetic patients through four major
pathways–polyol pathway, activation of advanced glycation
end products (AGEs), activation of hexosamine pathway and
activation of protein kinase C (PKC). Activated AGEs cause
receptor mediated oxidative stress and stimulate NF-κB protein
complex (Brownlee, 2001) which is capable of activates an
inflammatory response. Activation of this protein induces
the expression of iNOS, another essential enzyme in the
inflammatory process which binds to COX-2 and enhances its
activity through S-nitrosylation. Further, nerve damage causes
the activation of glial cells and releases the inflammatory
neuropoietic cytokines like TNF-α, IL-1β, and IL-6. These pro
inflammatory cytokines plays a major role in the development
of neuropathic pain in diabetic animals through neuronal
degeneration by p38 phosphorylation (Kim et al., 2005; Verri
et al., 2006; Cameron and Cotter, 2008; Edwards et al., 2008;
Kumar et al., 2012; Chanchal et al., 2016). In DN conditions,
mainly sciatic, femoral and peroneal nerves are affected (Deli
et al., 2014). Among all these major nerves, sciatic nerve that
originates from the spinal cord (L4-L6) (Schmalbruch, 1986)
is mainly affected in rats and responsible for pain. Diabetes
potentially affects all the spinal cord glial cells which were
reported in STZ induced diabetic rats. This activated microglia
up regulates the sodium channels and cause sensory changes
in dorsal root ganglia (DRG) (Schreiber et al., 2015). Apart
from proinflammatory cytokines, antiinflammatory cytokine IL-
10 play a crucial role in pathogenesis of DNP. Nerve injury
causes the significant reduction of IL-10 in DNP patients
which is a potential marker of the disease (Lees et al., 2013).
In this study, DN animals with no drug treatment showed
significantly lower levels of IL-10. ARBME, ARWF, ZJME, and
ZJWF treatment potentially inhibited NF-κB, iNOS expression
and related proinflammatory cytokines in sciatic nerve of DN
rats and showed increase levels of IL-10. Reduction of this
inflammatory cascade in the sciatic nerve might aid in reducing
the inflammatory damage in neurons of diabetic animals. Earlier
reports suggest that strict hyperglycemic control fails to inhibit
the neuropathic condition. This condition might be due to the
release of the early neuropoietic cytokines like TNF-α, IL-1β,
and IL-6 at the interphase of hyperglycemia induced biochemical
changes and nerve damage. In this study insulin treatment alone
fails to control the inflammatory markers and related pain in
animals (Skundric and Lisak, 2003), whereas supplement of
ARBME, ARWF, ZJME, and ZJWF along with insulin inhibit the
same. The results of inflammatory cytokines reveal that ARBME,
ARWF, ZJME, and ZJWF act peripherally to reduce the DNP.
ROS generation and related oxidative stress are other major
factors in the development of the neuropathic condition in
diabetic animals. In the hyperglycemic state, autoxidation
of monosaccharides leads to production of severe oxidative
stress. Superoxide and hydroxyl radicles mainly cause vascular
Frontiers in Cellular Neuroscience | www.frontiersin.org 13 March 2017 | Volume 11 | Article 73
Kandimalla et al. Effect of A. reticulata and Z. jujuba on Diabetic Neuropathy
FIGURE 9 | Schematic representation of possible mechanism of action
of active plant fractions of Annona reticulata bark and Ziziphus jujuba
root bark against painful diabetic neuropathy. ARBME, A. reticulata bark
methanol extract; ARBWF, A. reticulata bark water fraction; ZJME, Z. jujuba
root bark methanol extract; ZJWF, Z. jujuba root bark water fraction.
impairment and endoneurial hypoxia through oxidative damage.
Antioxidant enzymes (SOD, CAT, and GSH) provide defense
against these oxidative markers which plays an important role
in cytoprotection. Nerve cells are penurious in these antioxidant
enzymes (Naik et al., 2006) that neutralizes the ROS produced
in DN condition. Overproduction of ROS causes total utilization
of these antioxidant enzymes in the nerve tissue. These reduced
levels of antioxidant enzymes in DN state can act as a marker
for oxidative damage. Previous reports also stated that sciatic
nerve of DN animals contains significantly lower levels of SOD,
CAT, and GSH (Aziza et al., 2014; Ozyigit et al., 2015). Plant
phytochemicals can neutralize the ROS and reduces the burden
on antioxidant enzymes in neutralizing the same. So, supplement
of plant fractions reduces the ROS in DN animals, resulted in
the restoration of antioxidant enzymes to normal levels. Further
in DN condition, significant increase in LPO was observed
which relates to the overproduction of ROS and reduced levels
of antioxidant enzymes. All these factors collectively lead to
the impairment of neuronal functions (Bonnefont-Rousselot,
2002; Pop-Busui et al., 2002). In this study, diabetic animals
treated with ARBME, ARWF, ZJME, and ZJWF along with
insulin neutralizes the ROS and provided the protection against
oxidative damage and inflammation to sciatic nerve cells. We
also hypothesized that treatment with the plant fractions also
protects all the other major nerves from oxidative damage that
affected in DNP condition. Previous reports on antioxidant and
anti-inflammatory potential A. reticulata and Z. jujuba further
strengthen the present study (Chavan et al., 2012a,b; Kandimalla
et al., 2016a,e). Where, both plant bioactive fraction shows
protection against DNP through reducing oxidative stress and
inflammatory cytokines.
ARBWF and ZJWF showed strong response than ARBME
and ZJME in reducing the diabetic neuropathy in all the tests
conducted. We hypothesized that strong antioxidant ability of
both ARBWF and ZJWF neutralizes the harmful ROS and
prevent the lesions of pancreatic beta cells. Where, both the
fractions at higher dose further decrease the blood glucose
levels compare to insulin treatment alone (Hosseini et al., 2015).
Further, both the plant fractions showed significant protection
toward nerve fiber from oxidative damage and reduced the
pain sensation. The results were comparable with standard
drug pregabalin which was reported to have analgesic, anti-
inflammatory, anxiolytic and antioxidant property. Pregabalin
also have anti-hyperalgesic and anti-allodynia activity in animals
with neuropathic pain (Aswar et al., 2014). In this study,
pregabalin treatment along with insulin cause significant
protection from DNP through inhibiting oxidative stress and
inflammatory cytokines. Schematic representation of mechanism
of action of active plant fractions was given in Figure 9. The
present study explains that chemical constituents of A. reticulata
and Z. jujuba attenuate the DNP through acting both centrally
(pain reduction in animal models) and peripherally (reduction of
oxidative stress and inflammatory protein markers). Biomarker
isolation from both the plants are undergoing at drug discovery
laboratory, IASST, Guwahati-35, Assam, India.
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